Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Zbyšek Pavelek, Michal Novotný, Blanka Klímová, Marek Peterka, Pavel Potužník, Martina Kövári & Martin Vališ. (2021) DORADA adherence study: full view into RebiSmart subdomains parameters in multiple sclerosis treatment. Current Medical Research and Opinion 37:4, pages 589-596.
Read now
Read now
Francesco Patti, María Luisa Martínez Ginés, Christiane Norenberg & Fernando Duarte Caron. (2020) BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT®. Patient Preference and Adherence 14, pages 771-779.
Read now
Read now
Quentin Lohmeyer, Andreas Schneider, Christoph Jordi, Jakob Lange & Mirko Meboldt. (2019) Toward a new age of patient centricity? The application of eye-tracking to the development of connected self-injection systems. Expert Opinion on Drug Delivery 16:2, pages 163-175.
Read now
Read now
Sibyl Wray, Brooke Hayward, Fernando Dangond & Barry Singer. (2018) Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study. Expert Opinion on Drug Delivery 15:2, pages 127-135.
Read now
Read now
V Limmroth, J Reischl, B Mann, X Morosov, A Kokoschka, I Weller & T Schreiner. (2017) Autoinjector preference among patients with multiple sclerosis: results from a national survey. Patient Preference and Adherence 11, pages 1325-1334.
Read now
Read now